Skip to content

Therapeutic Efficacy and Mechanism of Yuyang Shuangbai Liquid in Promoting Wound Healing of Granulomatous Mastitis

Therapeutic Efficacy and Mechanism of Yuyang Shuangbai Liquid in Promoting Wound Healing of Granulomatous Mastitis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001517
Enrollment
Unknown
Registered
2025-07-30
Start date
2025-07-20
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Granulomatous mastitis

Interventions

Treatment group:Yu Yang Shuang bai ye
Control group:kang fu xin ye

Sponsors

Shuguang Hospital affiliated to Shanghai University of TCM
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Patients whose pathological findings meet the diagnostic criteria for granulomatous mastitis. 2. Women aged 18–50 years. 3. Patients who have undergone abscess drainage with the postoperative wound left open. 4. Intraoperative cultures of pus or exudate showing no bacterial growth. 5. Patients receiving postoperative wound-care dressings. 6. Patients who have provided written informed consent.

Exclusion criteria

Exclusion criteria: 1. Pregnancy. 2. Presence of other chronic internal medical conditions, such as organic heart or cerebrovascular disease, severe respiratory, digestive, hematologic, urinary, neurological, or endocrine disorders, major psychiatric illness, or autoimmune disease. 3. Coexisting severe illnesses (e.g., malignant tumors) or any condition that may interfere with the study. 4. Positive bacterial culture from intraoperative pus or secretions. 5. Use of corticosteroids or immunosuppressive agents during the treatment period. 6. Concurrent use of other medications or participation in additional therapies that could influence study outcomes. 7. Refusal to accept the proposed study or treatment protocol. 8. Known hypersensitivity to the study medication or inability to complete the trial for any other reason.

Design outcomes

Primary

MeasureTime frame
overall wound healing rate;

Secondary

MeasureTime frame
wound condition;wound bacterial culture results;pain measurement;serum;

Countries

China

Contacts

Public ContactQu wenchao

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

87608551@qq.com13818012233

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026